AstraZeneca PLC Form 6-K Filing

This filing is an SEC Form 6-K report for AstraZeneca PLC, filed in September 2026. It details the admission of further securities to trading on the London Stock Exchange's Main Market. Specifically, 10,072 ordinary shares of $0.25 each were issued and admitted between August 1, 2026, and August 31, 2026, under a block admission dated January 29, 2021. These new shares are fully fungible with existing ordinary shares, bringing the total number of securities in issue to 1,551,043,461. The report also includes information about the issuer, such as its Legal Entity Identifier (LEI), and confirms that the company is not submitting the Form 6-K in paper. AstraZeneca PLC is a global, science-led biopharmaceutical company focused on oncology, rare diseases, and biopharmaceuticals.